A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and effectiveness of scheduled and as
needed treatment of psoriasis with infliximab. Infliximab (Remicade) targets specific
proteins in the body's immune system to help control the development of inflammation to help
reduce painful disease.